Marchionni, Luigi
Weill Cornell Medicine
5 papers on CoChatORCID 0000-0002-7336-8071
Most cited papers
- Verified
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy
Ravi, R., Noonan, K. A., Pham, V., Bedi, R., Zhavoronkov, A., Ozerov, I. V., Makarev, E., V. Artemov, A., Wysocki, P. T., Mehra, R., et al. (2018) · Nature Communications
Cancer Immunotherapy and BiomarkersTGF-β signaling in diseases
Cited by 325
- Verified
Federated benchmarking of medical artificial intelligence with MedPerf
Karargyris, A., Umeton, R., Sheller, M. J., Aristizabal, A., George, J., Wuest, A., Pati, S., Kassem, H., Zenk, M., Baid, U., et al. (2023) · Nature Machine Intelligence
Artificial Intelligence in Healthcare and EducationPrivacy-Preserving Technologies in Data
Cited by 188
- Verified
Dysregulation of EGFR Pathway in EphA2 Cell Subpopulation Significantly Associates with Poor Prognosis in Colorectal Cancer
De Robertis, M., Loiacono, L., Fusilli, C., Poeta, M. L., Mazza, T., Sanchez, M., Marchionni, L., Signori, E., Lamorte, G., Vescovi, A. L., et al. (2017) · Clinical Cancer Research
Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research
Cited by 78
- Verified
Molecular Effects of Genistein on Male Urethral Development
Ross, A. E., Marchionni, L., Phillips, T. M., Miller, R. M., Hurley, P. J., Simons, B. W., Salmasi, A. H., Schaeffer, A. J., Gearhart, J. P., & Schaeffer, E. M. (2011) · Journal of Urology
Urological Disorders and TreatmentsEffects and risks of endocrine disrupting chemicals
Cited by 29
- Verified
Type 1 interferon perturbates clonal competition by reshaping human blood development
Lama, C., Isakov, D., Rosenberg, S., Quijada-Álamo, M., Saurty-Seerunghen, M. S., Moein, S., Nozais, M., Abera, T.-A., Sakaguchi, O., Totwani, M., et al. (2026) · Nature Genetics
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free